On Saturday, the fans of the fastest man of the world, Usain Bolt will see him running at the Daegu where men’s 200m final is being held. The chances of Usain Bolt are highest as throughout the tournament he has remained unbeatable.
Expectations are being hold of Bolt running much faster as he did while making a world record. Two years back, Bolt made a world record of completing the 100 meter track in just 19.19 sec. Daegu is one of his favorite events.
Earlier on Friday, Bolt easily won the 200 meter men’s semifinal. It seems like he is mentally and physically ready to beat the participants on Saturday. With Bolt, Nickel Ashmeade and Walter Dix, who belongs to the US, will also be seen racing.
These two will definitely through a tough competition to Bolt. Ashmeade is famous among youngsters when he won the silver medal in the 2008 World Junior Championships. Dix is also quite famous for his speed as he has booked victory twice at the US championships.
When it comes to speed, Bolt is definitely the fastest man in the world, but Ashmeade and Dix are also the fastest as they are capable of finishing 100 meter race in 19.95sec and 19.69sec respectively.
According to a post published to Microsoft’s official blog on Wednesday, the number of devices running the company’s latest Windows version — the Windows 10 operating system — has touched 350 million.
The new milestone in the Windows 10…
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies…
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle…
The Verge has revealed in a Wednesday report, citing a statement released by Lexus, that the working of the head units of a number of vehicles has been affected because of an over-the-air (OTA) update recently rolled out by the company.
…
The drought conditions in California is widening economic split in California. The prospect of…
Tech giant Google posted a video of a developer presentation to the Google Developers YouTube…
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won’t seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said…
In a Tuesday announcement, Adobe revealed that it has...
With the computer business having witnessed steep losses...
In a scenario where the government of the nations are...
After the event that was the 'hot-news' of the week, the...
© 2024 AustrianTribune
